| |
| |
|
| Insider
Information: |
Wolff Stefani |
| Relationship: |
EVP and COO |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
6,113 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
6,113 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Principia Biopharma Inc |
PRNB |
Chief Development Offi... |
2020-09-28 |
0 |
|
0 |
Premium* |
|
|
Nurix Therapeutics, Inc. |
NRIX |
EVP and COO |
2023-05-01 |
6,113 |
2022-04-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NRIX |
Nurix Therapeutics, Inc. |
EVP and COO |
• – – |
2023-05-01 |
4 |
S |
$9.88 |
$3,378 |
D/D |
(342) |
6,113 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
EVP and COO |
• – – |
2023-04-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
962 |
6,455 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
EVP and COO |
• – – |
2023-01-30 |
4 |
S |
$11.78 |
$4,995 |
D/D |
(424) |
3,940 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
EVP and COO |
• – – |
2023-01-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
962 |
4,364 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
EVP and COO |
• – – |
2022-10-31 |
4 |
S |
$12.88 |
$4,508 |
D/D |
(350) |
3,402 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
EVP and COO |
• – – |
2022-10-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
962 |
3,752 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
EVP and COO |
• – – |
2022-08-01 |
4 |
S |
$15.67 |
$5,579 |
D/D |
(356) |
1,238 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
EVP and COO |
• – – |
2022-07-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
962 |
1,594 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
EVP and COO |
• – – |
2022-05-02 |
4 |
S |
$11.75 |
$3,878 |
D/D |
(330) |
632 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
EVP and COO |
• – – |
2022-04-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
962 |
962 |
0 |
- |
|
| PRNB |
Principia Biopharma Inc |
Chief Development Officer |
• – – |
2020-09-28 |
4 |
D |
$100.00 |
$1,359,200 |
D/D |
(13,592) |
0 |
0 |
- |
|
| PRNB |
Principia Biopharma Inc |
Chief Development Officer |
• – – |
2020-09-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,504 |
13,592 |
0 |
- |
|
| PRNB |
Principia Biopharma Inc |
Chief Development Officer |
• – – |
2020-06-15 |
4 |
AS |
$59.89 |
$334,385 |
D/D |
(5,504) |
19,096 |
0 |
% |
|
| PRNB |
Principia Biopharma Inc |
Chief Development Officer |
• – – |
2020-03-16 |
4/A |
AS |
$45.72 |
$254,031 |
D/D |
(5,504) |
24,600 |
0 |
- |
|
| PRNB |
Principia Biopharma Inc |
Chief Development Officer |
• – – |
2020-03-16 |
4 |
AS |
$45.72 |
$254,031 |
D/D |
(5,504) |
35,609 |
0 |
% |
|
| PRNB |
Principia Biopharma Inc |
Chief Development Officer |
• – – |
2020-03-16 |
4 |
OE |
$4.54 |
$24,999 |
D/D |
5,504 |
41,113 |
0 |
- |
|
| PRNB |
Principia Biopharma Inc |
Chief Development Officer |
• – – |
2019-12-16 |
4/A |
AS |
$49.29 |
$272,091 |
D/D |
(5,505) |
30,104 |
0 |
- |
|
| PRNB |
Principia Biopharma Inc |
Chief Development Officer |
• – – |
2019-12-16 |
4 |
AS |
$49.29 |
$272,091 |
D/D |
(5,505) |
35,609 |
0 |
- |
|
| PRNB |
Principia Biopharma Inc |
Chief Development Officer |
• – – |
2019-12-16 |
4 |
OE |
$4.54 |
$25,004 |
D/D |
5,505 |
41,114 |
0 |
- |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
